We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+10.57%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$46B
AUM Growth
+$1.44B
Cap. Flow
-$2.24B
Cap. Flow %
-4.88%
Top 10 Hldgs %
24.5%
Holding
1,018
New
105
Increased
238
Reduced
409
Closed
154

Sector Composition

Rank Sector Weight
1 Technology 26.38%
2 Healthcare 17.14%
3 Financials 11.58%
4 Consumer Discretionary 10.01%
5 Industrials 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMA
726
ImageneBio Inc
IMA
$63M
$2.54M 0.01%
+32,325
New +$2.32M
NEX
727
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$2.5M 0.01%
280,000
-20,000
-7% -$165K
DTM icon
728
DT Midstream
DTM
$14.1B
$2.48M 0.01%
50,000
HUM icon
729
Humana
HUM
$43.7B
$2.48M 0.01%
5,540
-168,900
-97% -$85M
AMR icon
730
Alpha Metallurgical Resources
AMR
$1.74B
$2.47M 0.01%
+15,000
New +$2.29M
NTLA icon
731
Intellia Therapeutics
NTLA
$1.49B
$2.45M 0.01%
60,000
-3,000
-5% -$122K
CRL icon
732
Charles River Laboratories
CRL
$11.2B
$2.34M 0.01%
11,148
+3,343
+43% +$665K
MANU icon
733
Manchester United
MANU
$3.97B
$2.34M 0.01%
95,853
-54,263
-36% -$1.12M
NWS icon
734
News Corp Class B
NWS
$16.9B
$2.31M 0.01%
117,034
-1,000
-0.8% -$18.3K
OVV icon
735
Ovintiv
OVV
$17.3B
$2.28M 0.01%
60,000
-1,084,949
-95% -$39.2M
SYRS
736
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2.27M ﹤0.01%
721,914
NVAX icon
737
Novavax
NVAX
$1.2B
$2.23M ﹤0.01%
+300,000
New +$2.36M
OLMA icon
738
Olema Pharmaceuticals
OLMA
$1B
$2.09M ﹤0.01%
231,433
-188,567
-45% -$1.14M
BPMC
739
DELISTED
Blueprint Medicines
BPMC
$2.08M ﹤0.01%
+32,903
New +$1.79M
LRMR icon
740
Larimar Therapeutics
LRMR
$397M
$2.04M ﹤0.01%
651,680
AGNC icon
741
AGNC Investment
AGNC
$12.4B
$2.03M ﹤0.01%
+200,000
New +$1.94M
HCC icon
742
Warrior Met Coal
HCC
$4.19B
$1.95M ﹤0.01%
+50,000
New +$1.81M
SMAR
743
DELISTED
Smartsheet Inc.
SMAR
$1.91M ﹤0.01%
50,000
IMRX icon
744
Immuneering
IMRX
$267M
$1.77M ﹤0.01%
175,000
-30,000
-15% -$288K
BMEA icon
745
Biomea Fusion
BMEA
$84.6M
$1.76M ﹤0.01%
80,000
-1,653,251
-95% -$51.7M
WAT icon
746
Waters Corp
WAT
$37B
$1.72M ﹤0.01%
6,466
-32,999
-84% -$9.18M
WPC icon
747
W.P. Carey
WPC
$16.8B
$1.69M ﹤0.01%
+25,525
New +$1.77M
LNTH icon
748
Lantheus
LNTH
$6.49B
$1.68M ﹤0.01%
+20,000
New +$1.79M
MRSN
749
DELISTED
Mersana Therapeutics
MRSN
$1.65M ﹤0.01%
+20,000
New +$2.93M
W icon
750
Wayfair
W
$11.2B
$1.63M ﹤0.01%
+25,000
New +$1.05M

Similar funds

Adage Capital Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Adage Capital Partners held 1,018 positions worth $46B, up 3.2% from $44.6B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Adage Capital Partners withdrew a net $2.24B in Q2 2023, closing 154 positions and reducing 409 holdings. Its most notable exit was Shaw Communications Inc., an estimated $137M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Adage Capital Partners opened a new position in Palo Alto Networks worth $70.6M.

  • Adage Capital Partners's largest Q2 2023 buy was Palo Alto Networks: 553,000 shares worth $70.6M.
  • Adage Capital Partners added most to Boeing in Q2 2023, an estimated $181M increase.
  • Adage Capital Partners's biggest Q2 2023 reduction was Chipotle Mexican Grill, cutting an estimated $209M.
  • Adage Capital Partners fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $137M.
  • Adage Capital Partners's ten largest holdings make up 25% of its $46B portfolio in Q2 2023.
  • Adage Capital Partners opened 105 new positions and closed 154 in Q2 2023.
  • Adage Capital Partners's portfolio value rose 3.2% quarter-over-quarter to $46B.

Based on Adage Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.